↓ Skip to main content

Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma

Overview of attention for article published in BMC Cancer, April 2024
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

blogs
1 blog
twitter
6 X users

Readers on

mendeley
3 Mendeley